For example, in patients with osteoporosis, osteocyte-secreted Sclerostin can cross the blood–brain barrier, inhibit neuronal Wnt/β-catenin signaling, and promote β-amyloid (Aβ) accumulation, thus accelerating cognitive decline (37). Here, SOST is linked to osteoporosis.